Cyclo Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYTH and other ETFs, options, and stocks.

About CYTH

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. 

CEO
Nathan Scott Fine
CEONathan Scott Fine
Employees
9
Employees9
Headquarters
Gainesville, Florida
HeadquartersGainesville, Florida
Founded
1990
Founded1990
Employees
9
Employees9

CYTH Key Statistics

Market cap
17.55M
Market cap17.55M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
51.30K
Average volume51.30K
High today
$2.21
High today$2.21
Low today
$2.05
Low today$2.05
Open price
$2.21
Open price$2.21
Volume
15.39K
Volume15.39K
52 Week high
$8.30
52 Week high$8.30
52 Week low
$1.69
52 Week low$1.69

CYTH Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.